BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7868168)

  • 1. Mast cells and macrophages in endometrial lesions.
    D'Souza OA; Rameshkumar K; Nirmala V
    Indian J Pathol Microbiol; 1994 Oct; 37(4):367-73. PubMed ID: 7868168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of endometrial cells on cervical cytology.
    Yancey M; Magelssen D; Demaurez A; Lee RB
    Obstet Gynecol; 1990 Dec; 76(6):1000-5. PubMed ID: 2234706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial hyperplasia and carcinoma in endometrial polyps: clinicopathologic and follow-up findings.
    Mittal K; Da Costa D
    Int J Gynecol Pathol; 2008 Jan; 27(1):45-8. PubMed ID: 18156974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of premalignant and malignant pathology in endometrial polyps.
    Bakour SH; Khan KS; Gupta JK
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):317-20. PubMed ID: 10746849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma.
    Hamid AA; Mandai M; Konishi I; Nanbu K; Tsuruta Y; Kusakari T; Kariya M; Kita M; Fujii S
    Cancer; 2002 Feb; 94(4):997-1005. PubMed ID: 11920468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial hyperplasia involving endometrial polyps: report of a series and discussion of the significance in an endometrial biopsy specimen.
    Kelly P; Dobbs SP; McCluggage WG
    BJOG; 2007 Aug; 114(8):944-50. PubMed ID: 17565613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential diagnosis of endometrial hyperplasia and carcinoma by computerized image cytometry of cell proliferation, apoptosis and Bcl-2 expression.
    Mora LB; Diaz JI; Cantor AB; Nicosia SV
    Ann Clin Lab Sci; 1999; 29(4):308-15. PubMed ID: 10528831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precursors of endometrial clear cell carcinoma.
    Fadare O; Liang SX; Ulukus EC; Chambers SK; Zheng W
    Am J Surg Pathol; 2006 Dec; 30(12):1519-30. PubMed ID: 17122507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atypical endometrial hyperplasia: characteristics of histopathological diagnosis in curettings].
    Roa JC; Chuaqui R; Le Cerf P
    Rev Chil Obstet Ginecol; 1993; 58(5):388-92. PubMed ID: 7991860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between simple and atypical endometrial hyperplasia and endometrial carcinoma].
    Borisov I; Maĭnkhard K; Tsankova M
    Akush Ginekol (Sofiia); 1996; 35(4):18-20. PubMed ID: 9254559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
    Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
    Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hysteroscopic appearance of malignant and benign endometrial lesions: a case-control study.
    Zola FE; Nogueira AA; de Andrade JM; Candido dos Reis FJ
    Arch Gynecol Obstet; 2007 Jan; 275(1):49-52. PubMed ID: 16912853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AgNORs in endometrial lesions.
    Kaushik R; Sharma S; Mahajan V; Gulati A; Sharma BB
    Indian J Pathol Microbiol; 1999 Oct; 42(4):451-4. PubMed ID: 11127377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and follow-up of atypical hyperplasia of corpus endometrium--a critical methodological investigation.
    Geppert M; Smyczek-Gargya B; Menton M
    Zentralbl Gynakol; 1993; 115(11):492-4. PubMed ID: 8296494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
    Ma XX; Zhang SL; Gao S; Lu JM; Dong F
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
    Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
    Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of the tumour marker CA-125 in normal, hyperplastic and malignant endometrial tissue.
    Mylonas I; Makovitzky J; Richter DU; Jeschke U; Briese V; Friese K
    Anticancer Res; 2003; 23(2A):1075-80. PubMed ID: 12820350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of benign endometrial cells in Pap smears from postmenopausal women.
    Wu HH; Schuetz MJ; Cramer H
    J Reprod Med; 2001 Sep; 46(9):795-8. PubMed ID: 11584479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic imbalances in endometrial hyperplasia and endometrioid carcinoma detected by comparative genomic hybridization.
    Muslumanoglu HM; Oner U; Ozalp S; Acikalin MF; Yalcin OT; Ozdemir M; Artan S
    Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):107-14. PubMed ID: 15866096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.